Leveraging Covalency to Achieve Optimal Pharmacokinetic Profiles for Radiotherapeutics
Time: 1:45 pm
day: Day Two
Details:
- Introduction to Radiotherapeutics and why they require a unique pharmacokinetic profile
- Discuss the concept of covalency and how it fits in Radiotherapeutics
- Provide examples of covalency in developing superior Radiotherapeutics – an example from the FAP (fibroblast activation protein) field
